Savant Capital, LLC Jazz Pharmaceuticals PLC Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
A detailed history of Savant Capital, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Savant Capital, LLC holds 3,022 shares of JAZZ stock, worth $326,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,022
Previous 2,208
36.87%
Holding current value
$326,587
Previous $271,000
38.38%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
598Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$664 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$650 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$267 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$252 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$213 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.77B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...